Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer

[img]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB
[img] Other (Supplementary Information)
85MB

Item Type:Article
Title:USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer
Creators Name:Nelson, J.K. and Thin, M.Z. and Evan, T. and Howell, S. and Wu, M. and Almeida, B. and Legrave, N. and Koenis, D. S. and Koifman, G. and Sugimoto, Y. and Llorian Sopena, M. and MacRae, J. and Nye, E. and Howell, M. and Snijders, A.P. and Prachalias, A. and Zen, Y. and Sarker, D. and Behrens, A.
Abstract:Deubiquitylating enzymes (DUBs) play an essential role in targeted protein degradation and represent an emerging therapeutic paradigm in cancer. However, their therapeutic potential in pancreatic ductal adenocarcinoma (PDAC) has not been explored. Here, we develop a DUB discovery pipeline, combining activity-based proteomics with a loss-of-function genetic screen in patient-derived PDAC organoids and murine genetic models. This approach identifies USP25 as a master regulator of PDAC growth and maintenance. Genetic and pharmacological USP25 inhibition results in potent growth impairment in PDAC organoids, while normal pancreatic organoids are insensitive, and causes dramatic regression of patient-derived xenografts. Mechanistically, USP25 deubiquitinates and stabilizes the HIF-1α transcription factor. PDAC is characterized by a severely hypoxic microenvironment, and USP25 depletion abrogates HIF-1α transcriptional activity and impairs glycolysis, inducing PDAC cell death in the tumor hypoxic core. Thus, the USP25/HIF-1α axis is an essential mechanism of metabolic reprogramming and survival in PDAC, which can be therapeutically exploited.
Keywords:Pancreatic Ductal Carcinoma, Tumor Cell Line, Glycolysis, Pancreatic Neoplasms, Tumor Microenvironment, Ubiquitin Thiolesterase, Animals, Mice
Source:Nature Communications
ISSN:2041-1723
Publisher:Nature Publishing Group
Volume:13
Number:1
Page Range:2070
Date:19 April 2022
Official Publication:https://doi.org/10.1038/s41467-022-29684-9
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library